Status:
COMPLETED
Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Lead Sponsor:
Imelda GI Clinical Research Center
Conditions:
Crohn Disease
Ulcerative Colitis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This is a comparative pragmatic trial in patients with UC and CD on maintenance treatment with IFX. All IBD patients from cohort A with maintenance IFX treatment at a referral IBD clinic are prospecti...
Eligibility Criteria
Inclusion
- all adult IBD patients treated for at least 14 weeks with infliximab were included
Exclusion
- induction treatment with infliximab (\<14 weeks)
- treatment with other biological for IBD
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT04775732
Start Date
June 1 2018
End Date
September 30 2019
Last Update
August 5 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Imelda GI clinical research center
Bonheiden, Belgium, 2820
2
AZ Sint Lucas
Ghent, Belgium, 9000